Last update: Jan. 6, 2021
Minimal risk for breastfeeding and infant.
Penicillin that is resistant to staphylococcal penicillinase.
Administered orally or intravenously every 6 hours.
Like most penicillins (Nau 1987) it is excreted through breast milk in clinically insignificant amounts (Muysson 2020, Matsuda 1984) therefore there is no published data or even the expectation that problems could arise on the breastfeeding infants of mothers because of taking this drug
Widely used in the treatment of mastitis due to its excellent antibiotic activity against
Staphylococcus that are resistant to benzylpenicillin (Amir 2014 y 2011, Spencer 2008, Nordeng 2003, Bodley 2000).
The possibility of transitory gastroenteritis due to intestinal microbiome disruption should be taken into account (Briggs 2017, Ito 1993).
We do not have alternatives for J01CF01 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM